![]() | Up a level |
2022
Butzer, Sarina, Hennies, Imke, Gimpel, Charlotte, Gellermann, Jutta, Schalk, Gesa, Koenig, Sabine, Buescher, Anja K., Lemke, Anja and Pohl, Martin (2022). Early clinical course of biopsy-proven IgA vasculitis nephritis. BMC Pediatr., 22 (1). LONDON: BMC. ISSN 1471-2431
2020
Burgmaier, Kathrin, Ariceta, Gema, Bald, Martin, Buescher, Anja Katrin, Burgmaier, Mathias, Erger, Florian, Gessner, Michaela, Gokce, Ibrahim, Koenig, Jens, Kowalewska, Claudia, Massella, Laura, Mastrangelo, Antonio, Mekahli, Djalila, Pape, Lars, Patzer, Ludwig, Potemkina, Alexandra, Schalk, Gesa, Schild, Raphael, Shroff, Rukshana, Szczepanska, Maria, Taranta-Janusz, Katarzyna ORCID: 0000-0002-8762-8866, Tkaczyk, Marcin
ORCID: 0000-0003-1753-7560, Weber, Lutz Thorsten, Wuehl, Elke, Wurm, Donald, Wygoda, Simone, Zagozdzon, Ilona, Doetsch, Joerg, Oh, Jun, Schaefer, Franz and Liebau, Max Christoph
ORCID: 0000-0003-0494-9080
(2020).
Severe neurological outcomes after very early bilateral nephrectomies in patients with autosomal recessive polycystic kidney disease (ARPKD).
Sci Rep, 10 (1).
BERLIN:
NATURE RESEARCH.
ISSN 2045-2322
2019
Zhao, Fei, Afonso, Sara, Lindner, Susanne, Hartmann, Andrea, Loeschmann, Ina, Nilsson, Bo ORCID: 0000-0003-0057-2730, Ekdahl, Kristina N., Weber, Lutz T., Habbig, Sandra, Schalk, Gesa, Kirschfink, Michael, Zipfel, Peter F. and Skerka, Christine
(2019).
C3-Glomerulopathy Autoantibodies Mediate Distinct Effects on Complement C3-and C5-Convertases.
Front. Immunol., 10.
LAUSANNE:
FRONTIERS MEDIA SA.
ISSN 1664-3224
2015
Michelfelder, Stefan, Schalk, Gesa, Wuehl, Elke, Hoppe, Bernd, Beringer, Ortraud, Pohl, Martin and Haeffner, Karsten (2015). Complement analysis, clinical monitoring and treatment of complement dysfunction in C3 glomerulonephritis (C3G). Mol. Immunol., 67 (1). S. 162 - 163. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 0161-5890
Schalk, Gesa, Ehren, Rasmus, Koerber, Friederike and Weber, Lutz T. (2015). Magnetic resonance imaging findings in atypical hemolytic uremic syndrome with cerebral involvement. Mol. Immunol., 67 (1). S. 178 - 179. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 0161-5890
Schalk, Gesa, Gessner, Michaela, Hoppe, Bernd, Zipfel, Peter and Weber, Lutz T. (2015). Eculizumab in dense deposit disease - A promising therapy option. Mol. Immunol., 67 (1). S. 178 - 180. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 0161-5890
Schalk, Gesa, Habbig, Sandra, Beck, Bodo B., Licht, Christoph, Hoppe, Bernd and Weber, Lutz T. (2015). Plasmatherapy - Still first line treatment in atypical hemolytic uremic syndrome? Long-term follow-up of four patients. Mol. Immunol., 67 (1). S. 177 - 179. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 0161-5890
Schalk, Gesa, Taylan, Christina, Ehren, Rasmus and Weber, Lutz (2015). FOCAL AND SEGMENTAL GLOMERULOSCLEROSIS (FSGS) AND SUCCESSFUL LONG-TERM THERAPY WITH PLASMAPHERESIS. Pediatr. Nephrol., 30 (9). S. 1698 - 1700. NEW YORK: SPRINGER. ISSN 1432-198X
Schalk, Gesa, Taylan, Christina, Gessner, Michaela, Zipfel, Peter, Doetsch, Joerg and Weber, Lutz T. (2015). Dense deposit disease with autoantibodies against C3 convertase and C3 activation products in a 7-year old girl - potential value of combined C5-blockade and immunoadsorption. Mol. Immunol., 67 (1). S. 178 - 179. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 0161-5890
2014
Schalk, Gesa, Ehren, Rasmus, Vierzig, Anne, Kirschfink, Michael, Bergmann, Carsten, Hoppe, Bernd and Weber, Lutz Thorsten (2014). A Complicated Case Of Atypical Hemolytic Uremic Syndrom With Frequent Relapses Under Eculizumab. Pediatr. Nephrol., 29 (9). S. 1818 - 1819. NEW YORK: SPRINGER. ISSN 1432-198X
Schalk, Gesa, Habbig, Sandra, Licht, Christoph, Hoppe, Bernd and Weber, Lutz Thorsten (2014). Plasmatherapy - Still First Line Treatment In Atypical Hemolytic Uremic Syndrome? Long-term Follow-up Of Four Patients. Pediatr. Nephrol., 29 (9). S. 1697 - 1698. NEW YORK: SPRINGER. ISSN 1432-198X
Schalk, Gesa, Taylan, Christina, Gessner, Michaela, Zipfel, Peter, Doetsch, Joerg and Weber, Lutz Thorsten (2014). Dense Deposit Disease With Autoantibodies Against C3 Convertase And C3 Activation Products In A 7-year Old Girl - Potential Value Of Combined C5-blockade And Immunoadsorption. Pediatr. Nephrol., 29 (9). S. 1750 - 1752. NEW YORK: SPRINGER. ISSN 1432-198X
Wehling, Cyrill, Amon, Oliver, Bommer, Martin, Hoppe, Bernd, Kentouche, Karim, Schalk, Gesa, Weimer, Rolf, Wiesener, Michael, Tonshoff, Burkhard and Kirschfink, Michael (2014). Complement activation biomarkers under Eculizumab treatment in patients with atypical hemolytic-uremic syndrome (aHUS), membrano-proliferative glomerulonephritis (MPGN) and antibody-mediated renal graft rejection (AMR). Mol. Immunol., 61 (2). S. 259 - 260. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 0161-5890